Pro Share Advisors LLC Aptinyx Inc. Transaction History

Pro Share Advisors LLC

  • $36.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$3.0 - $4.08 $33,783 - $45,944
-11,261 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$2.95 - $4.38 $4,770 - $7,082
-1,617 Reduced 12.56%
11,261 $38,000
Q1 2019

May 15, 2019
BUY
$3.99 - $19.33 $490 - $2,377
123 Added 0.96%
12,878 $52,000
Q4 2018

Feb 14, 2019
BUY
$16.15 - $28.93 $205,993 - $369,002
12,755 New
12,755 $211,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email